QCM
AURA icon

Quantinno Capital Management’s Aura Biosciences AURA Stock Holding History

Quantinno Capital Management’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$928K Buy
130,656
+39,581
+43% +$283K ﹤0.01% 2615
2026
Q1 		$609K Buy
91,075
+54,694
+150% +$314K ﹤0.01% 2567
2025
Q4 		$198K Sell
36,381
-8,260
-19% -$49K ﹤0.01% 3052
2025
Q3 		$276K Buy
44,641
+22,769
+104% +$149K ﹤0.01% 2524
2025
Q2 		$137K Buy
+21,872
New +$128K ﹤0.01% 2453

Other funds holding AURA

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Quantinno Capital Management's AURA Position: Q2 2026 in Review

Quantinno Capital Management increased its Aura Biosciences (AURA) stake by 43% in Q2 2026, buying an estimated $283K and bringing the position to 130,656 shares worth $928K. The position accounts for ﹤0.01% of the portfolio, ranked #2615.

Quantinno Capital Management first reported a position in AURA in Q2 2025 and has held it in 5 quarters since. 147 funds tracked by Wall St. Rank hold AURA as of Q2 2026.

  • Quantinno Capital Management held 130,656 shares of Aura Biosciences worth $928K as of Q2 2026.
  • Quantinno Capital Management bought 39,581 Aura Biosciences shares in Q2 2026, an estimated $283K.
  • Aura Biosciences made up ﹤0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #2615 holding.
  • Quantinno Capital Management first reported a position in Aura Biosciences in Q2 2025 and has held it in 5 quarters since.
  • 147 funds tracked by Wall St. Rank held Aura Biosciences as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.